NF-κB p50 and p52 Expression Is Not Required for RANK-Expressing Osteoclast Progenitor Formation but Is Essential for RANK- and Cytokine-Mediated Osteoclastogenesis
- 1 July 2002
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 17 (7) , 1200-1210
- https://doi.org/10.1359/jbmr.2002.17.7.1200
Abstract
Expression of RANKL by stromal cells and of RANK and both NF-kappaB p50 and p52 by osteoclast precursors is essential for osteoclast formation. To examine further the role of RANKL, RANK, and NF-KB signaling in this process, we used NF-kappaB p50-/- ;p52-/- double knockout (dKO) and wild-type (WT) mice. Osteoclasts formed in cocultures of WT osteoblasts with splenocytes from WT mice but not from dKO mice, a finding unchanged by addition of RANKL and macrophage colony-stimulating factor (M-CSF). NF-kappaB dKO splenocytes formed more colony-forming unit granulocyte macrophage (CFU-GM) colonies than WT cells, but no osteoclasts were formed from dKO CFU-GM colonies. RANKL increased the number of CFU-GM colonies twofold in WT cultures but not in dKO cultures. Fluorescence-activated cell sorting (FACS) analysis of splenocytes from NF-kappaB dKO mice revealed a two-to threefold increase in the percentage of CD11b (Mac-1) and RANK double-positive cells compared with WT controls. Treatment of NF-kappaB dKO splenocytes with interleukin (IL)-1, TNF-alpha, M-CSF, GM-CSF, and IL-6 plus soluble IL-6 receptor did not rescue the osteoclast defect. No increase in apoptosis was observed in cells of the osteoclast lineage in NF-kappaB dKO or p50-/-;p52+/- (3/4KO) mice. Thus, NF-kappaB p50 and p52 expression is not required for formation of RANK-expressing osteoclast progenitors but is essential for RANK-expressing osteoclast precursors to differentiate into TRAP+ osteoclasts in response to RANKL and other osteoclastogenic cytokines.Keywords
This publication has 51 references indexed in Scilit:
- Proposed Standard Nomenclature for New Tumor Necrosis Factor Family Members Involved in the Regulation of Bone ResorptionJournal of Bone and Mineral Research, 2000
- Characterization of osteoclast precursors in human bloodBritish Journal of Haematology, 2000
- Expression of functional RANK on mature rat and human osteoclastsFEBS Letters, 1999
- RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in OsteoclastogenesisBiochemical and Biophysical Research Communications, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Requirement for NF-κB in osteoclast and B-cell developmentGenes & Development, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Interleukin-1α Activates an NF-κB-like Factor in Osteoclast-like CellsPublished by Elsevier ,1996
- The Role of Reactive Oxygen Intermediates in Osteoclastic Bone ResorptionBiochemical and Biophysical Research Communications, 1995
- Structure, Regulation and Function of NF-kappaBAnnual Review of Cell Biology, 1994